Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT00748189 · TERMINATED
Trial details
- NCT number
- NCT00748189
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-22
- Primary completion
- 2013-03-20
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.